Factor Model (net +2.7)
Factor Model
net +2.7 6.0 / 10Q4 miss on both lines drives 10% premarket drop
Watch: Listen for management's explanation of the revenue shortfall and any revised 2026 guidance on the earnings call. Watch whether the company flags macro headwinds in elective vision correction or company-specific issues.
Staar Surgical Co reported Q4 results that fell short on both earnings and revenue. The company posted a loss of $0.13 per share against analyst expectations of a $0.06 profit. Revenue came in at $57.8 million, missing the $75.4 million consensus by 23%. Shares dropped 10.2% to $16.99 in premarket trading Wednesday.
The dual miss signals operational challenges and weaker-than-expected demand for Staar's implantable lenses. A 23% revenue shortfall isn't a rounding error — it suggests either deteriorating market conditions or execution issues that management will need to explain.
Evidence
7 older signals
Fundamentals & Data ▾
Recent transactions
Get alerted when STAA changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.